Evolent Health, Inc.
General ticker "EVH" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $1.1B (TTM average)
Evolent Health, Inc. does not follow the US Stock Market performance with the rate: -16.4%.
Estimated limits based on current volatility of 3.5%: low 3.87$, high 4.14$
Factors to consider:
- Total employees count: 4500 as of 2024
- Top business risk factors: Labor/talent shortage/retention, Acquisition/divestiture risks, Stock price volatility affecting recruitment, Regulatory and compliance, Strategic risks and growth management
- Current price 40.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.70$, 17.18$]
- 2025-12-31 to 2026-12-31 estimated range: [5.87$, 14.54$]
Financial Metrics affecting the EVH estimates:
- Positive: with PPE of 16.9 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of -1.57
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: Investing cash flow per share per price, % of -4.91 <= -4.48
- Negative: 18.93 < Shareholder equity ratio, % of 39.35 <= 41.86
- Negative: Return on assets ratio (scaled to [-100,100]) of -2.36 <= 1.87
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term EVH quotes
Long-term EVH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,352.01MM | $1,955.79MM | $2,535.82MM |
| Operating Expenses | $1,348.37MM | $2,027.00MM | $2,576.30MM |
| Operating Income | $3.64MM | $-71.21MM | $-40.48MM |
| Non-Operating Income | $-65.72MM | $-131.19MM | $-22.55MM |
| Interest Expense | $15.57MM | $54.20MM | $24.72MM |
| Income(Loss) | $-62.08MM | $-202.41MM | $-63.04MM |
| Taxes | $-43.38MM | $-89.36MM | $-1.41MM |
| Other Income(Loss) | $-0.46MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-19.63MM | $-113.04MM | $-61.62MM |
| Stockholders Equity | $859.42MM | $1,067.70MM | $1,001.26MM |
| Assets | $1,817.29MM | $2,680.31MM | $2,544.41MM |
| Operating Cash Flow | $-11.55MM | $142.58MM | $18.77MM |
| Capital expenditure | $38.36MM | $28.75MM | $24.89MM |
| Investing Cash Flow | $-259.12MM | $-415.54MM | $-62.93MM |
| Financing Cash Flow | $131.54MM | $281.34MM | $-0.56MM |
| Earnings Per Share** | $-0.21 | $-1.02 | $-0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.